Abstracts

Atherosclerotic Cardiovascular Disease Risk Score and Cognition by HIV Serostatus and Sex

Background: Higher cardiovascular risk is associated with poorer cognitive health, including in people with HIV (PWH). We examined whether HIV modifies the association between the Atherosclerotic Cardiovascular Disease (ASCVD) Risk Estimator and subsequent cognition in the Multicenter AIDS Cohort Study (MACS) and Women’s Interagency HIV Study (WIHS). Methods: Participants followed in the MACS (N=1773 men,…

Brain White Matter Hyperintensity Accumulation in an Acute HIV Cohort Over 2 Years

Background: Development and progression of cerebral white matter hyperintensities (WMH) are associated with increased risk of stroke and cognitive impairment for people with (PWH) and without HIV (PWOH). Individuals with chronic HIV have greater WMH burden compared to PWOH despite viral suppression. Progression of WMH in relation to outcomes following onset of early antiretroviral therapy…

A New Measure of ART Activity in CSF and Association With Persistence and Cognitive Function

Background: ACTG A5321, a prospective study of HIV-1 reservoirs among persons with HIV on antiretroviral therapy (ART), previously showed detection of HIV DNA in cells from cerebrospinal fluid (CSF) was associated with poorer global cognitive function. We conducted a cross-sectional analysis of antiretroviral (ARV) pharmacokinetics (PK) in CSF and investigated relationships among a novel measure…

CSF Biomarker Evidence of Synaptic Dysfunction in Acute, but Not Post-Acute COVID-19

Background: CNS immune activation and neurocognitive symptoms are common in severe COVID-19, but mechanisms of persisting CNS dysfunction in post COVID-19 conditions (PCC; ‘long covid’) are unclear. We used a panel of CSF markers, several of whom have been implicated in Alzheimer’s disease (AD) and other neurodegenerative diseases to investigate synaptic and lysosomal dysfunction in…

Phenotyping Risk of Polypharmacy and Cognitive Impairment in ACTG A5322: “HAILO”

Background: Polypharmacy is associated with worse cognitive health among people with HIV (PWH), however explanatory models have not been established. This study leveraged data from a large and well characterized cohort of virally suppressed individuals age 40 and older to identify risk factors that explain the association between polypharmacy and cognitive impairment among PWH. Methods:…

Antiretroviral Regimens Are Associated With Cognitive Function in People With HIV

Background: While modern antiretroviral therapy (ART) is highly effective and safe overall, ART medications can cause neuropsychiatric adverse effects (e.g., poorer cognition). Observational studies addressing cognition have mainly focused on individual ART drugs rather than ART regimens, partly due to statistical limitations. We developed a novel statistical approach to examine the relationship between common ART…

Pro-Inflammatory Glycomic Dysregulations Define HIV-Associated Neurocognitive Impairments

Background: In the general population, host glycomic alterations drive inflammation and precede onset of inflammation-associated diseases. However, it remains unclear whether glycomic alterations are associated with development of inflammation-associated diseases, including neurocognitive impairment, in people with HIV (PWH) on suppressive antiretroviral therapy (ART). Methods: In this analysis conducted within the ACTG A5322 (HAILO), 20 PWH…

Retinoids Enhance NK Natural and Antibody-Dependent Cell Cytotoxicity of HIV-Infected CD4 T-Cells

Background: Novel approaches to sensitize latently infected cells to apoptosis may provide additional methods to eliminate latent reservoirs. Prior research identified several retinoids as potential drugs that increase the sensitivity of HIV-infected cells to cell death. Retinoids are derivatives of Vitamin A that target retinoic receptors causing antiproliferative and proapoptotic activity. Several are FDA-approved or…